Zeroing in on myofascial pain
Myofascial pain syndrome represents the largest group of poorly recognizd and undertreated acuate and chronic medical problems in clinical practice.
Myofascial pain syndrome (MFPS) represents the largest group of poorly recognized and undertreated acute and chronic medical problems in clinical practice.1 Its prevalence is estimated to be approximately 30% among patients seen in general medical clinics and as high as 85% in pain specialty clinics.2-5 The gynecologic literature cites chronic pelvic pain (CPP) as the most common indication for performing operative laparoscopy.6 CPP has been defined as noncyclic pain lasting at least 6 months that localizes to the anatomic pelvis, anterior abdominal wall, the lumbosacral back, or the buttocks and is severe enough to cause functional disability or necessitate medical care.7
What is myofascial pain syndrome?
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
